Market Overview

Target's Strong Q1, Guidance Send Shares Higher

Target's Strong Q1, Guidance Send Shares Higher

Target Corporation (NYSE: TGT) on Wednesday reported first-quarter earnings of $1.53 per share, which beat the analyst consensus estimate of $1.43. This is a 15.9 percent increase over earnings of $1.32 per share from the same period in 2018.

Target reported quarterly sales of $17.62 billion, which beat the analyst consensus estimate of $17.5 billion. This is a 5.04 percent increase over sales of $16.781 billion the same period last year.

Target sees second quarter EPS in a the range of $1.52-$1.72 versus a $1.59 estimate. The retailer sees FY2019 adjusted EPS $5.75-$6.05 versus a $5.83 estimate.

"Over the last two years, we have made important investments to build a durable operating and financial model that drives consumer relevance and sustainable growth. Target's first quarter performance and market-share gains demonstrate that the model is working,” said Target CEO Brian Cornell in the press release.

“Throughout this year, we will continue to extend the reach of our same-day fulfillment options, strengthen our portfolio of owned and exclusive brands, remodel and open more stores and invest in our team. We're confident that we're well-positioned to deliver strong financial performance in 2019 and beyond,".

Target shares were trading at around $76.30 per share Wednesday morning, higher by 6 percent.

Related Links:

Morgan Stanley Upgrades Target After Recent Pullback

The Street Reacts To Target's Q4 Earnings, Analyst Day

Photo by Mike Kalasnik/Wikimedia.

Posted-In: Earnings News Guidance Best of Benzinga


Related Articles (TGT)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

What You Need To Know About The FTC Win Over Qualcomm

The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study